Clinical trial
Evaluating the Efficacy of Bioptron° Light Therapy in Managing Primary Dysmenorrhea Among Obese Adolescence: Double Blinded Randomized Control Trial
NCT06992349 is registered in ClinicalTrials.gov with Alaa Noureldeen Kora as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Efficacy of Bioptron° Light Therapy in Managing Primary Dysmenorrhea Among Obese Adolescence: Double Blinded Randomized Control Trial
- Lead sponsor
- Alaa Noureldeen Kora
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- August 1, 2025
- Completion date
- August 31, 2025
- Enrollment
- 144 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dysmenorrhea primary, obesity and overweight